Literature DB >> 6106768

Naproxen levels in preterm infants after maternal treatment.

A R Wilkinson.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1980        PMID： 6106768     DOI： 10.1016/s0140-6736(80)92026-7

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  6 in total

Review 1.  A risk-benefit assessment of therapies for premature labour.

Authors:  K Higby; C R Suiter
Journal:  Drug Saf       Date:  1999-07       Impact factor: 5.606

Review 2.  Treatment of inflammatory rheumatic disorders in pregnancy: what are the safest treatment options?

Authors:  M Ostensen; R Ramsey-Goldman
Journal:  Drug Saf       Date:  1998-11       Impact factor: 5.606

Review 3.  Non-narcotic analgesics. Use in pregnancy and fetal and perinatal effects.

Authors:  M A Heymann
Journal:  Drugs       Date:  1986       Impact factor: 9.546

4.  Neonatal renal dysfunction and intrauterine exposure to prostaglandin synthesis inhibitors.

Authors:  U Simeoni; J Messer; P Weisburd; J Haddad; D Willard
Journal:  Eur J Pediatr       Date:  1989-01       Impact factor: 3.183

Review 5.  Clinical pharmacokinetics in the treatment of rheumatoid arthritis in pregnancy.

Authors:  F R Witter
Journal:  Clin Pharmacokinet       Date:  1993-12       Impact factor: 6.447

Review 6.  Optimisation of antirheumatic drug treatment in pregnancy.

Authors:  M Ostesen
Journal:  Clin Pharmacokinet       Date:  1994-12       Impact factor: 6.447
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.